scholarly article | Q13442814 |
P2093 | author name string | Zanetti G | |
Francioli P | |||
Zellweger JP | |||
Tissot F | |||
Zysset F | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tuberculin | Q29505 |
P304 | page(s) | 211-217 | |
P577 | publication date | 2004-12-20 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? | |
P478 | volume | 40 |
Q81686518 | A novel assay for screening patients for latent tuberculosis infection prior to anti-TNF therapy |
Q30047515 | Allergy Diagnostic Testing: An Updated Practice Parameter |
Q36518580 | An update on the diagnosis of tuberculosis infection |
Q24793402 | BCG vaccination at three different age groups: response and effectiveness |
Q56099092 | Comparison of QuantiFERON-TB Gold In-Tube Test and Tuberculin Skin Test for Identification of Latent Mycobacterium tuberculosis Infection in Healthcare Staff and Association Between Positive Test Results and Known Risk Factors for Infection |
Q44007235 | Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation |
Q58075093 | Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation |
Q92604809 | Correlation between the tuberculin skin test and T-SPOT.TB in patients with suspected tuberculosis infection: A pilot study |
Q53648894 | Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients. |
Q50545626 | Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. |
Q34450737 | Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing |
Q37343631 | Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran |
Q34369813 | Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth |
Q42014010 | Diagnosis of latent tuberculosis: Can we do better? |
Q33599396 | Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil. |
Q42625458 | Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro |
Q27470966 | Epidemiology and management of infectious diseases in international adoptees |
Q37206406 | Evaluation of the Immune Response to Interferon Gamma Release Assay and Tuberculin Skin Test Among BCG Vaccinated Children in East of Egypt: A Cross-Sectional Study |
Q40111089 | Improved Serodiagnostic Sensitivity of Strip Test for Latent Tuberculosis |
Q80337513 | Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration |
Q36843374 | Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients |
Q37514147 | Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact |
Q44082314 | Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists |
Q35199257 | Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy |
Q42923729 | Mycobacterium tuberculosis infection following kidney transplantation |
Q37685543 | Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers |
Q35139580 | Performance of a rapid strip test for the serologic diagnosis of latent tuberculosis in children |
Q40509845 | Potential role for interferon-γ release assays in tuberculosis screening in a remote Canadian community: a case series |
Q33497330 | Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam. |
Q36185964 | Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study |
Q54543517 | Preventing and treating biologic-associated opportunistic infections. |
Q37206147 | QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection |
Q37135291 | Recommendations for pediatric tuberculosis vaccination in Italy |
Q36639862 | Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor |
Q41404253 | Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit. |
Q92533010 | Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test |
Q42205252 | Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON®-TB Gold In-Tube test and tuberculin skin test. |
Q33494752 | T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination |
Q91834762 | The association between tuberculin skin test result and active tuberculosis risk of college students in Beijing, China: a retrospective cohort study |
Q54259381 | The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation. |
Q84960387 | Tuberculin Skin Test, Interferon-gamma Assay, and T Cells Subpopulations in Hemodialysis Patients |
Q39359277 | Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? |
Q34516560 | Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study |
Q30863509 | Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure |
Q36452353 | Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. |
Q53496785 | [Diagnostics for pulmonary tuberculosis in adults] |
Q84036425 | [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases] |
Q82795249 | [Tuberculosis : diagnostics and prophylaxis] |
Search more.